Unveiling the Future of Radiology: Key Trends from RSNA 2023

28 Dec 2023
medcitynews.com
Innovation was a central theme at the Radiological Society of North America’s (RSNA) 109th Scientific Assembly and Annual Meeting held recently in Chicago, and the discussions that took place there will inform the future of radiology in 2024 in beyond. RSNA 2023 showcased advancements across the healthcare spectrum from health policy and education to imaging informatics. Among the main topics discussed at the conference, three major trends stood out: the integration of artificial intelligence (AI), a renewed focus on health equity, and a dedicated effort to enhance the patient experience. Trend #1 – AI, tech and people as a service: AI is sweeping through radiology with unprecedented vigor. RSNA 2023 witnessed major industry players such as GE, Siemens, and Philips unveiling cutting-edge AI innovations that promise to revolutionize the field. The conference floor was abuzz with discussions on AI applications, with specific focus areas including AI in Breast Imaging, Pancreatic Tumor Imaging, and the emergence of teleradiology services to redefine diagnostic workflows and treatment. The fusion of technology and human expertise is becoming a hallmark of modern radiology. Radiologists are leveraging AI tools to enhance their diagnostic capabilities and improve patient outcomes. The conference sessions explored the practical applications of AI, demonstrating its potential to significantly impact the field and elevate the standard of patient care. Trend #2 – Health equity: The Covid-19 pandemic has underscored the importance of health equity, and radiology is no exception. RSNA 2023 dedicated sessions to delve into this critical aspect of healthcare, addressing issues such as the racial disparities in Alzheimer’s diagnoses and gender diversity in radiology. A study published by Boston Medical Center showed that Black patients face delays in Alzheimer’s diagnoses as compared to White and Hispanic patients. Lead author Joshua Wibecan, MD, noted that, “obtaining access to neuroimaging is one possible barrier that delays diagnosis.” Black patients received imaging for cognitive impairment at an older age and were more likely to receive a CT scan, as opposed to the more detailed MRI. Discussions around gender diversity focused on the need for more inclusion. Both the patients as well as workforce members who identify as transgender or nonbinary need to be supported in the field of radiology. Transgender employees discussed how radiology practices can adapt to serve a more inclusive population. The conversation also focused on a need to collect more comprehensive gender data to better support patients. The conference highlighted the pressing need for inclusivity and equal access to radiological services, echoing the broader call for a more equitable healthcare landscape. Trend #3 – Patient experience: While the radiology landscape undergoes a technological metamorphosis, the human aspect remains central. RSNA 2023 emphasized the imperative of improving patient experience, aligning it with the expectations set by consumer-centric industries. Discussions revolved around the symbiotic relationship between AI and patient-centered radiology. While the industry should embrace the latest technology, it should also work to preserve the human touch. The conference also echoed the need to reduce administrative burdens on radiologists, freeing up their time for more nuanced patient care. The integration of AI, the commitment to health equity, and the emphasis on patient experience collectively propel radiology into a future where innovation and compassion coexist harmoniously. RSNA continues to serve as a catalyst for change, shaping the trajectory of radiological medicine and inspiring professionals to push the boundaries of what’s possible.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.